The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study.

Autor: Porntharukchareon T; Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Chartisathian W; Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Navinpipat M; Hematology and Cell Therapy Unit, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Samdaengpan C; Division of Medical Oncology, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Cheirsilpa K; Gastroenterology and Hepatology Center, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Lueprasitsakul A; Hematology and Cell Therapy Unit, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Worawichawong S; Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Muangsillapasart V; Cardiovascular Center, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Pumuthaivirat P; Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Dechates B; Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Sirisreetreerux S; Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Siripongboonsitti T; Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand., Rangsrisaeneepitak V; Burapha University Hospital, Burapha University, Chonburi, Thailand., Jirawattanapalin K; Center of Learning and Research in Celebration of HRH Princess Chulabhorn's 60th Birthday Anniversary, Chulabhorn Royal Academy, Bangkok, Thailand., Tawinprai K; Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Aug 01; Vol. 19 (2), pp. 2251850.